Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Palbociclib plus letrozole in estrogen receptor-positive ... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial
0
Authors
Mansoor Mirza
19 more
Mansoor Mirza
•
Line Bjørge
17 more
•
Jalid Sehouli
Published
December 9, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Gynecologic Oncology
Topics
Medicine
Cancer Oncology
Pathology
Internal Medicine
Urology
Show all topics
DOI
10.1016/j.ygyno.2024.12.003
License
CC-BY
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Gynecologic Oncology
Topics
Medicine
Cancer Oncology
Pathology
Internal Medicine
Urology
Show all topics
DOI
10.1016/j.ygyno.2024.12.003
License
CC-BY
